The favorable climate of the pharmaceutical sector has changed radically over
the past ten years.
Where once near unrestricted revenue expansion existed, external pressures now
act in unison to restrict the industry's growth potential.
Investors, having received excellent returns on their investment, still demand
growth as a key measure of a company's success and strength.
Therefore, it is vital, more than ever before, that players understand the immediate
challenges facing the sector and develop measures to counter these hurdles over
the next five years.
If companies fail to do so, their achievable growth in revenues and earnings
will not keep pace with the double digit level that investors have historically
sought.
These companies will lag behind in the race for growth and fall into the 'earnings
gap'.
Bridging the Pharmaceutical Earnings Gap: Key strategies in the race for
growth draws upon extensive primary research from industry executives to
provide an overview of the present and future state of the pharmaceutical sector.
The report details the key threats to future growth and offers insightful analysis
as to how they work in combination to restrict growth and create the phenomenon
that is the earnings gap. The report also offers novel and insightful analyses
of the strategies for maintaining growth and assesses the role of each key tool
in overcoming these business development hurdles.
The creation of the earnings gap :
This section assesses and analyzes the concerted effect that immediate key pressures
have, and will continue to have, on a company's growth potential.
Key strategies for maximizing new revenue streams :
This section identifies and analyzes, with the help of insightful case studies,
the key aspects in the early stages of a product's lifecycle. This includes
strategic in-licensing, R&D pipeline speed and efficiency, approval issues and
launching and market penetration tools.
Key strategies for maximizing older revenue streams :
This section details the key features in the later stages of a product's lifecycle
and analyzes the effect that strong product management has on defending older
revenue streams, thereby narrowing a potential earnings gap.
Key strategies for improving earnings through corporate initiatives :
This section details the key features of both mergers and acquisitions and analyzes,
through the use of case studies and the impact that such activity can have on
company performance.
This section also identifies possible drivers and resistors to M&A in the immediate
future.
In addition, this section offers novel analysis of cost-control measures through
improved inventory management and manufacturing asset utilization.
